The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 59 (1) , 102583
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hematopoietic Stem-Cell Gene Therapy for Cerebral AdrenoleukodystrophyNew England Journal of Medicine, 2017
- Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort reportBlood, 2011
- Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2009
- Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison studyThe Lancet Neurology, 2007
- X-linked adrenoleukodystrophyNature Clinical Practice Neurology, 2007
- Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screeningThe Journal of Pediatrics, 2005
- Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999Blood, 2004
- Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophyThe Lancet, 2000
- Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controlsAnnals of Neurology, 1999
- Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapyBrain, 1997